000919 金陵藥業
按盤價 
6.550 +0.130 (+2.025%)
6.550 +0.130 (+2.025%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.088 | 3.302 | 3.556 | 4.170 | 2.271 |
| 總資產報酬率 ROA (%) | 1.441 | 2.191 | 2.342 | 2.763 | 1.543 |
| 投入資產回報率 ROIC (%) | 2.033 | 3.176 | 3.379 | 3.979 | 2.192 | 邊際利潤分析 |
| 銷售毛利率 (%) | 20.262 | 21.040 | 19.773 | 22.432 | 22.422 |
| 營業利潤率 (%) | 4.117 | 4.200 | 4.868 | 7.020 | 5.004 |
| 息稅前利潤/營業總收入 (%) | 3.519 | 3.442 | 4.064 | 6.290 | 4.509 |
| 淨利潤/營業總收入 (%) | 3.250 | 3.848 | 4.263 | 5.445 | 3.741 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 84.527 | 75.179 | 55.036 | 95.999 | 148.084 |
| 價值變動淨收益/利潤總額(%) | 12.034 | 14.054 | -9.568 | -1.358 | -10.988 |
| 營業外收支淨額/利潤總額(%) | 1.063 | 1.202 | -1.755 | -1.211 | -0.122 | 償債能力分析 |
| 流動比率 (X) | 3.513 | 2.759 | 3.043 | 2.674 | 2.560 |
| 速動比率 (X) | 3.236 | 2.440 | 2.753 | 2.387 | 2.291 |
| 資產負債率 (%) | 17.147 | 19.021 | 20.186 | 20.530 | 0.199 |
| 帶息債務/全部投入資本 (%) | 1.890 | 1.979 | 3.146 | 3.299 | 2.264 |
| 股東權益/帶息債務 (%) | 5,162.370 | 4,910.417 | 3,026.289 | 2,875.421 | 4,242.021 |
| 股東權益/負債合計 (%) | 413.184 | 351.512 | 326.399 | 320.638 | 336.004 |
| 利息保障倍數 (X) | -5.481 | -4.252 | -5.643 | -9.738 | -9.218 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 52.200 | 37.687 | 39.493 | 40.498 | 41.574 |
| 存貨周轉天數 (天) | 39.357 | 42.434 | 41.661 | 38.080 | 41.648 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 04/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
